Sphingomyelin containing preparation

Details Sphingomyelin containing preparation Sphingomyelin containing preparation

A - Human Necessities

61

K

A61K 45/06 (2006.01)

Patent

CA 2368676

Cytotoxic tumor therapy in a patient is enhanced by co-administration of sphingomyelin. The invention most likely enhances a tumor cell's ability to undergo ceramide-induced apoptosis by increasing the levels of sphingomyelin in all cellular compartments, thereby providing sufficient substrate for activated sphingomyelinase. A method of treating rheumatoid arthritis also is provided.

On peut améliorer le traitement cytotoxique d'une tumeur chez un patient par la co-administration de sphingomyéline. L'invention améliore vraisemblablement la capacité des cellules tumorales à subir une apoptose induite par des céramides en augmentant le taux de sphingomyéline dans tous les compartiments cellulaires, ce qui permet une production suffisante de substrat pour la sphyngomyélinase activée. L'invention concerne également une méthode permettant de traiter la polyarthrite rhumatoïde.

Affiliated with

Also associated with

Rating

Sphingomyelin containing preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sphingomyelin containing preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sphingomyelin containing preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1738257